PAX3-FKHR sensitizes human alveolar rhabdomyosarcoma cells to camptothecin-mediated growth inhibition and apoptosis.
about
The antiapoptotic function of miR-96 in prostate cancer by inhibition of FOXO1Glycogen synthase kinase 3 regulates PAX3-FKHR-mediated cell proliferation in human alveolar rhabdomyosarcoma cells.Trabectedin and Campthotecin Synergistically Eliminate Cancer Stem Cells in Cell-of-Origin Sarcoma ModelsA simple protocol for using a LDH-based cytotoxicity assay to assess the effects of death and growth inhibition at the same time.Protein phosphatase 2Cbetal regulates human pregnane X receptor-mediated CYP3A4 gene expression in HepG2 liver carcinoma cells.Carnitine palmitoyltransferase 1A (CPT1A): a transcriptional target of PAX3-FKHR and mediates PAX3-FKHR-dependent motility in alveolar rhabdomyosarcoma cellsCyclin-dependent kinase 4 phosphorylates and positively regulates PAX3-FOXO1 in human alveolar rhabdomyosarcoma cellsRegulation of Nuclear Receptor Nur77 by miR-124.Small molecule inhibition of PAX3-FOXO1 through AKT activation suppresses malignant phenotypes of alveolar rhabdomyosarcomaPAX3-FKHR regulates the expression of pleiotrophin to mediate motility in alveolar rhabdomyosarcoma cells.A call to ARMS: targeting the PAX3-FOXO1 gene in alveolar rhabdomyosarcoma.Molecular diagnostics in soft tissue sarcomas and gastrointestinal stromal tumors.HNRNPH1 is required for rhabdomyosarcoma cell growth and survival.Camptothecin exhibits topoisomerase1-independent KMT1A suppression and myogenic differentiation in alveolar rhabdomyosarcoma cells.
P2860
Q28535282-D20583F0-FF24-4573-8286-D109AC2D736AQ33615694-1F2397AE-67FE-46FF-8004-6FCFE0EF3174Q33649056-670D9120-7C3C-4969-ADA3-02DB5A3DBF7AQ34085713-28AC1384-DF72-4FBF-A19F-DFC7E322D897Q34127902-A5F4A2FC-5E36-495C-8C8E-1D8BD6774989Q34245749-0342AB38-5269-4CD9-A4EF-6C4D0A937D7FQ34612870-BFC1EAF9-EC4D-4BF4-BD65-1D943B489F0FQ35913193-286EDDFE-E814-41ED-8087-4BA6C606F6FAQ37381276-66AF62E3-E6AB-4F64-B6D1-5ACEFF20DBEEQ37384314-49F3CA0C-6FB5-4D56-8F58-C457777DC44CQ38083828-720CF2A4-6A40-45E3-BB17-0B7E338C2B67Q38378763-378F6EBC-22B2-48EE-BFF2-ECE67EE2AD0FQ51758996-EC445CEA-1322-41F5-9699-9E9C0FA9CF09Q55109900-5DA84CF0-4C63-4329-B09E-838317F73930
P2860
PAX3-FKHR sensitizes human alveolar rhabdomyosarcoma cells to camptothecin-mediated growth inhibition and apoptosis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 12 May 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
PAX3-FKHR sensitizes human alv ...... owth inhibition and apoptosis.
@en
PAX3-FKHR sensitizes human alv ...... owth inhibition and apoptosis.
@nl
type
label
PAX3-FKHR sensitizes human alv ...... owth inhibition and apoptosis.
@en
PAX3-FKHR sensitizes human alv ...... owth inhibition and apoptosis.
@nl
prefLabel
PAX3-FKHR sensitizes human alv ...... owth inhibition and apoptosis.
@en
PAX3-FKHR sensitizes human alv ...... owth inhibition and apoptosis.
@nl
P2093
P2860
P1433
P1476
PAX3-FKHR sensitizes human alv ...... owth inhibition and apoptosis.
@en
P2093
Fu-Yue Zeng
Lingling Liu
Taosheng Chen
P2860
P304
P356
10.1016/J.CANLET.2009.04.016
P407
P577
2009-05-12T00:00:00Z